Financhill
Buy
55

CORBF Quote, Financials, Valuation and Earnings

Last price:
$1.09
Seasonality move :
-2.13%
Day range:
$1.05 - $1.06
52-week range:
$0.25 - $2.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.66x
P/B ratio:
0.18x
Volume:
8.6K
Avg. volume:
4.9K
1-year change:
-16%
Market cap:
$140.6M
Revenue:
--
EPS (TTM):
--

Earnings Data

Next earnings date for CORBF
May 15
2025
Most recent earnings per share
$0.14
Beat by $0.14
(Mar 31/2022)
Consensus Estimate
--
(Mar 31/2022)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CORBF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2022 Q1 -- $46.8M $0.14 -- --
12/31/2021 Q4 -- $49.6M $0.17 -- --
09/30/2021 Q3 -- $48.4M $0.16 -- --
06/30/2021 Q2 -- $48.8M $0.17 -- --
03/31/2021 Q1 -- $46.6M $0.16 -- --
12/31/2020 Q4 -- $43.9M $0.14 -- --
09/30/2020 Q3 -- $41.2M $0.16 -- --
06/30/2020 Q2 -- $39.6M $0.15 -- --
03/31/2020 Q1 -- $43M $0.11 -- --
12/31/2019 Q4 -- $47.5M $0.17 -- --
09/30/2019 Q3 -- $44.7M $0.14 -- --
06/30/2019 Q2 -- $40.1M $0.13 -- --
03/31/2019 Q1 -- $37.3M $0.11 -- --
12/31/2018 Q4 -- $36.8M $0.07 -- --
09/30/2018 Q3 -- $36.3M $0.08 -- --
06/30/2018 Q2 -- $36.7M $0.10 -- --
03/31/2018 Q1 $39.4M $36.6M $0.04 $0.13 -$0.09
12/31/2017 Q4 $38.3M $37M $0.09 $0.13 -$0.04
09/30/2017 Q3 -- $35.2M $0.09 -- --
06/30/2017 Q2 -- $32.7M $0.09 -- --
03/31/2017 Q1 -- $29.3M $0.07 -- --
12/31/2016 Q4 -- $29.1M $0.10 -- --
09/30/2016 Q3 -- $27.6M $0.03 -- --
06/30/2016 Q2 $26.2M $26.5M $0.03 $0.03 $0.00
03/31/2016 Q1 -- $24M $0.03 -- --
12/31/2015 Q4 -- $26.5M $0.10 -- --
09/30/2015 Q3 -- $27.2M $0.04 -- --
06/30/2015 Q2 -- $26.6M $0.03 -- --

Global Cord Blood Earnings Questions

  • How Much did Global Cord Blood Generate in Revenue Last Quarter?

    Global Cord Blood reported $46.8M worth of top line sales in its most recent quarter.

  • Did Global Cord Blood Beat Earnings Last Quarter?

    Global Cord Blood announced earnings per share of $0.14 which represents a beat of analyst forecast a -- per share.

  • Is Global Cord Blood Profitable?

    Global Cord Blood reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Global Cord Blood EPS Next Year?

    Global Cord Blood's earnings are forecast to grow from -- per share to -- per share next year representing an increase of --.

  • When is Global Cord Blood's Earnings Date?

    Global Cord Blood's next earnings date is May 15, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
63
SKX alert for May 6

Skechers USA [SKX] is down 0.07% over the past day.

Sell
20
PTCT alert for May 6

PTC Therapeutics [PTCT] is down 11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock